Navigation Links
GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
Date:2/23/2011

ATLANTA, Feb. 23, 2011 /PRNewswire/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) announced today the publication of the results of Phase 1 clinical trial testing of its HIV/AIDS vaccine products. The article, titled "Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles," will appear in the March 1 issue of The Journal of Infectious Diseases. A PDF of the article is available at the following URL:

http://jid.oxfordjournals.org/cgi/reprint/jiq105?ijkey=nT44dx1yCxsiOjV&keytype=ref.

GeoVax is developing two vaccine components: a recombinant DNA-vectored vaccine; and a recombinant MVA-vectored vaccine. Both produce non-infectious virus-like particles in the body of a vaccine recipient. These non-infectious particles are designed to "train" the immune system of the vaccinated person to recognize HIV should the vaccinated person be exposed to the real virus. Both the DNA and MVA vaccines induce humoral (antibody) and cellular (T cell) responses. Antibodies have the potential to block virus before it infects cells. The T cells have the potential to recognize and kill cells that become infected by virus that gets past the antibody.

The publication reports the results of three different trial regimens:  (1) priming with two doses of the pGA2/JS7 recombinant DNA vaccine and boosting with two doses of MVA/HIV62B recombinant MVA vaccine (DDMM regimen); (2) priming with one dose of the recombinant DNA and boosting with two doses of the recombinant MVA (DMM regimen); and (3) priming and boosting with a total of three doses of the recombinant MVA vaccine (MMM regimen). The Phase 1 trial, initiated in 2006 and completed in 2009, included 120 participants, was sponsored by
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
2. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
3. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
4. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
5. GeoVax Labs Engages The Investor Relations Group
6. GeoVax Labs, Inc. Reports Fourth Quarter and Year End 2009 Financial Results
7. GeoVax Labs, Inc. Plans Public Offering
8. GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA
9. FDA Grants GeoVax Labs, Inc. Request For Pre-IND Meeting
10. GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update
11. GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... LEWIS CENTER, Ohio , May 22, 2013 ... of Opioid Defense Manager™ (ODM).  Launched in November ... Medical,s revolutionary managed care program to stop the ... ODM is a proactive, customized program designed to ... drug use while maintaining the necessary balance to ...
(Date:5/22/2013)... , May 22, 2013  MGT Capital Investments, Inc. ... present at the Second Annual Marcum LLP MicroCap Conference ... York City at the Grand Hyatt Hotel.  ... Executive Officer, will update investors and answer questions. ... Company,s presentation is scheduled to begin at 9:30 a.m. ...
(Date:5/22/2013)... WORCESTER, Mass. and TORONTO ... www.generex.com ) (OTCBB: GNBT) today announced three presentations demonstrating ... developed by its wholly-owned subsidiary, Antigen Express, Inc. ( ... annual meeting of the American Society of Clinical Oncology ... from May 31 through June 4, 2013. ...
Breaking Medicine Technology:Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4
(Date:5/22/2013)... York, New York (PRWEB) May 22, 2013 ... the nation’s first trial involving a da Vinci lawsuit, ... the case, the family of a man who allegedly died ... seeking more than $8 million in damages from Intuitive Surgical, ... down its physician training program for the da Vinci Surgical ...
(Date:5/22/2013)... Miami, FL (PRWEB) May 22, 2013 ... New York Daily News article titled "Breast ... better sports bras could help." According to ... and found that a substantial amount suffer from breast ... sports bra to correct the issue. , Zensah ...
(Date:5/22/2013)... Pass, OR (PRWEB) May 22, 2013 People ... and it is leading to water shortages. In much of ... luxury, according to water advocate, Sharon Kleyne. She warns against ... conserve the water that is available so easily in the ... Kleyne Hour Power of Water radio show, heard live or ...
(Date:5/22/2013)... May 22, 2013 Diversity Focus and ... This! The performance promotes awareness that physical disabilities ... Handicap This! performance will be held Friday, June 14th ... auditorium. Tickets for Handicap This! can be purchased ... audiences measure the level to which their mind is ...
(Date:5/22/2013)... challenges previous research that suggests umpire discrimination exists ... collaboration between researchers at U-M and the universities ... controversial argument over whether MLB umpires discriminate by ... same race. It found little statistical evidence to ... of sport management at the U-M School of ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2
... other members of bipartisan,group of Capitol Hill veterans ... trade, labor and employment,and tax policy, WASHINGTON, ... campaign, one thing is certain: change is coming ... regulated by the federal government,will face a new ...
... Pa., Nov. 4 /PRNewswire/ Capital BlueCross announced the,launch of ... and the,Lehigh Valley, called BlueCross Dental. No specific date ... but it is slated to be available to,customers in ... become the most popular,dental plan in our region because ...
... Misonix, Inc.,(Nasdaq: MSON ), today announced ... leading supplier of after market products, services,and test ... ultrasound,probe study in Sweden at the country,s annual ... paper was presented by the School,for Technology and ...
... research published in the November 4, 2008 issue of ... Academy of Neurology, found that ADHD affects the motor ... improvement of motor skills in children with and without ... Md. found that girls with ADHD and their typically ...
... Inc.,(NYSE: HSP ), a global specialty pharmaceutical ... Begley, chairman and chief,executive officer, and Thomas E. ... will make a formal presentation at the 2008,Annual ... 12, 2008, in,Phoenix., The presentation is scheduled ...
... Alexion,Pharmaceuticals, Inc. (Nasdaq: ALXN ) today announced ... Pharmaceuticals, will present at,two upcoming investor conferences, one ... Suisse., Dr. Bell will present at Deutsche ... p.m. Eastern Time, on Tuesday, November 11,2008. Dr. ...
Cached Medicine News:Health News:Venable's 'Election Watch Group' Assesses Presidential Election's Impact on Multiple Industries 2Health News:Venable's 'Election Watch Group' Assesses Presidential Election's Impact on Multiple Industries 3Health News:Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study 2Health News:Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study 3Health News:Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study 4Health News:Study finds ADHD affects motor skills of boys more than girls 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: